Evidence map›Paper›PMID 18566116›Full record

ArticleEndocrinology2008

Steroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor subtypes.

Heather A Molenda-Figueira, Suzanne D Murphy, Katherine L Shea, Nora K Siegal, Yingxin Zhao, Joseph G Chadwick, Larry A Denner, Marc J Tetel

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The Role of Progesterone Receptors in Breast Cancer.Drug design, development and therapy · 2022
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Convergence of multiple mechanisms of steroid hormone action.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2012
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Heather A Molenda-FigueiraCenter for Neuroendocrine Studies, Neuroscience, and Behavior Program, University of Massachusetts, Amherst, MA 01003, USA.
Suzanne D Murphy
Katherine L Shea
Nora K Siegal
Yingxin Zhao
Joseph G Chadwick
Larry A Denner
Marc J Tetel
Skidmore College · USThe University of Texas Medical Branch at Galveston · USUniversity of Massachusetts Amherst · USWellesley College · US

Funding

The Neural Basis of Sexually Dimorphic Brain FunctionR01MH047538 · NIMH · UNIVERSITY OF MASSACHUSETTS AMHERST · PI DE VRIES, GEERT J. · 1991 to 2013
$3.2M
Mechanisms of Steroid Hormone Action in BrainR01DK061935 · NIDDK · WELLESLEY COLLEGE · PI TETEL, MARC JEFFREY · 2002 to 2014
$2.7M
NIDDK NIH HHS R01 DK061935NIDDK NIH HHS R01 DK61935NIMH NIH HHS R01 MH047538NIMH NIH HHS T32MH47538
6 · The paper itself

Abstract

In vitro studies reveal that nuclear receptor coactivators enhance the transcriptional activity of steroid receptors, including estrogen (ER) and progestin receptors (PR), through ligand-dependent interactions. Whereas work from our laboratory and others shows that steroid receptor coactivator-1 (SRC-1) is essential for efficient ER and PR action in brain, very little is known about receptor-coactivator interactions in brain. In the present studies, pull-down assays were used to test the hypotheses that SRC-1 from hypothalamic and hippocampal tissue physically associate with recombinant PR or ER in a ligand-dependent manner. SRC-1, from hypothalamus or hippocampus, interacted with PR-A and PR-B in the presence of an agonist, but not in the absence of ligand or in the presence of a selective PR modulator, RU486. Interestingly, SRC-1 from brain associated more with PR-B, the stronger transcriptional activator, than with PR-A. In addition, SRC-1 from brain, which was confirmed by mass spectrometry, interacted with ERalpha and ERbeta in the presence of agonist but not when unliganded or in the presence of the selective ER modulator, tamoxifen. Furthermore, SRC-1 from hypothalamus, but not hippocampus, interacted more with ERalpha than ERbeta, suggesting distinct expression patterns of other cofactors in these brain regions. These findings suggest that interactions of SRC-1 from brain with PR and ER are dependent on ligand, receptor subtype, and brain region to manifest the pleiotropic functional consequences that underlie steroid-regulated behaviors. The present findings reveal distinct contrasts with previous cell culture studies and emphasize the importance of studying receptor-coactivator interactions using biologically relevant tissue.

Indexed as

AnimalsEstrogen AntagonistsEstrogen Receptor alphaEstrogen Receptor betaFemaleGlutathione TransferaseHippocampusHistone AcetyltransferasesHormone AntagonistsHypothalamusLigandsMass SpectrometryMifepristoneNuclear Receptor Coactivator 1RatsRats, Sprague-DawleyEstrogen AntagonistsEstrogen Receptor alphaEstrogen Receptor betaGlutathione TransferaseHistone AcetyltransferasesHormone AntagonistsLigandsMifepristoneNuclear Receptor Coactivator 1Receptors, ProgesteroneRecombinant ProteinsTamoxifenTranscription Factors

Identifiers

PMID18566116
PMCPMC2582912
OpenAlexW2130899928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.